Sequential Chemotherapy with Gemcitabine and Docetaxel: Breaking the Chains of bacillus Calmette-Guérin.
作者信息
Meeks Joshua J, Sexton Wade J, Clark Peter E
机构信息
Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois.
Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida.
出版信息
J Urol. 2022 Sep;208(3):526-527. doi: 10.1097/JU.0000000000002779. Epub 2022 May 13.
PMID:35549526
Abstract
摘要
相似文献
1
Sequential Chemotherapy with Gemcitabine and Docetaxel: Breaking the Chains of bacillus Calmette-Guérin.
J Urol. 2022 Sep;208(3):526-527. doi: 10.1097/JU.0000000000002779. Epub 2022 May 13.
2
Re: Sequential Intravesical Gemcitabine and Docetaxel for Bacillus Calmette-Guérin-naïve High-risk Nonmuscle-invasive Bladder Cancer.回复：吉西他滨和多西他赛序贯膀胱内灌注治疗初治的卡介苗耐药高危非肌层浸润性膀胱癌
Eur Urol. 2022 Dec;82(6):659. doi: 10.1016/j.eururo.2022.08.024. Epub 2022 Sep 8.
3
Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer.序贯膀胱内吉西他滨和多西他赛治疗卡介苗初治高危非肌层浸润性膀胱癌。
J Urol. 2022 Sep;208(3):589-599. doi: 10.1097/JU.0000000000002740. Epub 2022 Jul 27.
4
The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial.经膀胱内吉西他滨联合 1/3 剂量卡介苗灌注治疗对非肌层浸润性膀胱癌患者生活质量的影响：一项前瞻性、随机、Ⅱ期临床试验的结果。
J Urol. 2013 Sep;190(3):857-62. doi: 10.1016/j.juro.2013.03.097. Epub 2013 Mar 29.
5
Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure.卡介苗治疗失败后的高危非肌肉浸润性膀胱癌行膀胱内吉西他滨灌注治疗。
J Urol. 2013 Nov;190(5):1686-91. doi: 10.1016/j.juro.2013.04.120. Epub 2013 May 7.
6
Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for BCG-unresponsive Non-muscle-invasive bladder cancer: Pro.序贯吉西他滨联合多西他赛是卡介苗无反应性非肌层浸润性膀胱癌的标准二线膀胱内治疗方法：专家观点
Eur Urol Focus. 2022 Jul;8(4):1117-1120. doi: 10.1016/j.euf.2021.07.018. Epub 2021 Sep 27.
7
Intracavitary bacillus Calmette-Guérin for Superficial Bladder Tumors.腔内卡介苗治疗浅表性膀胱肿瘤。
J Urol. 2017 Feb;197(2S):S146-S147. doi: 10.1016/j.juro.2016.10.083. Epub 2016 Dec 20.
8
9
A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guérin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the Bladder.卡巴他赛、吉西他滨和顺铂膀胱内灌注治疗卡介苗无反应或复发性/转移性非肌肉浸润性膀胱癌的 I 期临床试验。
J Urol. 2020 Aug;204(2):247-253. doi: 10.1097/JU.0000000000000919. Epub 2020 Mar 2.
10
Sequential intravesical gemcitabine-docetaxel vs. bacillus Calmette-Guerin (BCG) in the treatment of non-muscle invasive bladder cancer: A preliminary cost-effectiveness analysis.序贯膀胱内注射吉西他滨-多西他赛与卡介苗（BCG）治疗非肌层浸润性膀胱癌的初步成本效益分析
Urol Oncol. 2023 Sep;41(9):391.e1-391.e4. doi: 10.1016/j.urolonc.2023.04.005. Epub 2023 Apr 29.
Zotero 插件